![Claire Deselle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Claire Deselle
Chairman at Maine Venture Fund
Claire Deselle active positions
Companies | Position | Start | End |
---|---|---|---|
Maine Venture Fund
![]() Maine Venture Fund Investment ManagersFinance Maine Venture Fund is a venture capital firm founded in 1995. The firm is headquartered in Newport, Maine. | Director/Board Member | - | - |
Chairman | - | - | |
Private Equity Investor | - | - |
Career history of Claire Deselle
Former positions of Claire Deselle
Companies | Position | Start | End |
---|---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
CS-Keys, Inc.
![]() CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | President | - | - |
Training of Claire Deselle
University of Pennsylvania | Masters Business Admin |
Statistics
International
United States | 5 |
Operational
President | 1 |
Masters Business Admin | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Private companies | 2 |
---|---|
CS-Keys, Inc.
![]() CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | Health Technology |
Maine Venture Fund
![]() Maine Venture Fund Investment ManagersFinance Maine Venture Fund is a venture capital firm founded in 1995. The firm is headquartered in Newport, Maine. | Finance |
- Stock Market
- Insiders
- Claire Deselle
- Experience